

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1715/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1715" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding Crimean–Congo hemorrhagic fever virus" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding Crimean&ndash;Congo hemorrhagic fever virus.">
            <meta name="og:description" content="Read the latest article version by David W. Hawman, Heinz Feldmann, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17678">
            <meta name="article-id" content="16189">
            <meta name="dc.title" content="Recent advances in understanding Crimean&ndash;Congo hemorrhagic fever virus">
            <meta name="dc.description" content="Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed hemorrhagic fever virus and the cause of hemorrhagic disease in Africa, Southern and Eastern Europe, the Middle East, India and Asia. Recent emergence of CCHFV into Spain indicates that the geographic range of this virus is expanding and the presence of its tick vector in several countries without reported disease suggest that CCHFV will continue to spread. Research into CCHFV was historically limited by a lack of suitable animal models and tools to study viral pathogenesis. However, in the past few years the toolset for studying CCHFV has expanded with small animal and non-human primate models for CCHFV being developed along with a reverse genetics system that allows for investigation of viral determinants of disease. These tools have been utilized to understand how CCHFV antagonizes host restriction factors and to develop novel vaccine candidates that may help limit the substantial morbidity and mortality in humans caused by CCHFV.">
            <meta name="dc.subject" content="Crimean-Congo hemorrhagic fever virus, CCHFV, CCHF disease, pathogenesis, animal models, vaccines, antivirals">
            <meta name="dc.creator" content="Hawman, David W.">
            <meta name="dc.creator" content="Feldmann, Heinz">
            <meta name="dc.date" content="2018/10/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.16189.1">
            <meta name="dc.source" content="F1000Research 2018 7:1715">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Crimean-Congo hemorrhagic fever virus">
            <meta name="prism.keyword" content="CCHFV">
            <meta name="prism.keyword" content="CCHF disease">
            <meta name="prism.keyword" content="pathogenesis">
            <meta name="prism.keyword" content="animal models">
            <meta name="prism.keyword" content="vaccines">
            <meta name="prism.keyword" content="antivirals">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/10/29">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1715">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.16189.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1715">
            <meta name="citation_title" content="Recent advances in understanding Crimean&ndash;Congo hemorrhagic fever virus">
            <meta name="citation_abstract" content="Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed hemorrhagic fever virus and the cause of hemorrhagic disease in Africa, Southern and Eastern Europe, the Middle East, India and Asia. Recent emergence of CCHFV into Spain indicates that the geographic range of this virus is expanding and the presence of its tick vector in several countries without reported disease suggest that CCHFV will continue to spread. Research into CCHFV was historically limited by a lack of suitable animal models and tools to study viral pathogenesis. However, in the past few years the toolset for studying CCHFV has expanded with small animal and non-human primate models for CCHFV being developed along with a reverse genetics system that allows for investigation of viral determinants of disease. These tools have been utilized to understand how CCHFV antagonizes host restriction factors and to develop novel vaccine candidates that may help limit the substantial morbidity and mortality in humans caused by CCHFV.">
            <meta name="citation_description" content="Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed hemorrhagic fever virus and the cause of hemorrhagic disease in Africa, Southern and Eastern Europe, the Middle East, India and Asia. Recent emergence of CCHFV into Spain indicates that the geographic range of this virus is expanding and the presence of its tick vector in several countries without reported disease suggest that CCHFV will continue to spread. Research into CCHFV was historically limited by a lack of suitable animal models and tools to study viral pathogenesis. However, in the past few years the toolset for studying CCHFV has expanded with small animal and non-human primate models for CCHFV being developed along with a reverse genetics system that allows for investigation of viral determinants of disease. These tools have been utilized to understand how CCHFV antagonizes host restriction factors and to develop novel vaccine candidates that may help limit the substantial morbidity and mortality in humans caused by CCHFV.">
            <meta name="citation_keywords" content="Crimean-Congo hemorrhagic fever virus, CCHFV, CCHF disease, pathogenesis, animal models, vaccines, antivirals">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="David W. Hawman">
            <meta name="citation_author_institution" content="Laboratory of Virology, Division of Intramural Research, NIAID/NIH, Hamilton, Montana, 59840, USA">
            <meta name="citation_author" content="Heinz Feldmann">
            <meta name="citation_author_institution" content="Laboratory of Virology, Division of Intramural Research, NIAID/NIH, Hamilton, Montana, 59840, USA">
            <meta name="citation_publication_date" content="2018/10/29">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1715">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.16189.1">
            <meta name="citation_firstpage" content="1715">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1715/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1715.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17678 /> <input type=hidden id=articleId name=articleId value=16189 /> <input type=hidden id=xmlUrl value="/articles/7-1715/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1715-v1.xml"> <input type=hidden id=article_uuid value=27cff07b-d1b3-4e12-95b6-e1ea53e7709b /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding Crimean–Congo hemorrhagic fever virus"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.16189.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.16189.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1715"
  },
  "headline": "Recent advances in understanding Crimean–Congo hemorrhagic fever virus",
  "datePublished": "2018-10-29T16:12:08",
  "dateModified": "2018-10-29T16:12:08",
  "author": [
    {
      "@type": "Person",
      "name": "David W. Hawman"
    },    {
      "@type": "Person",
      "name": "Heinz Feldmann"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed hemorrhagic fever virus and the cause of hemorrhagic disease in Africa, Southern and Eastern Europe, the Middle East, India and Asia. Recent emergence of CCHFV into Spain indicates that the geographic range of this virus is expanding and the presence of its tick vector in several countries without reported disease suggest that CCHFV will continue to spread. Research into CCHFV was historically limited by a lack of suitable animal models and tools to study viral pathogenesis. However, in the past few years the toolset for studying CCHFV has expanded with small animal and non-human primate models for CCHFV being developed along with a reverse genetics system that allows for investigation of viral determinants of disease. These tools have been utilized to understand how CCHFV antagonizes host restriction factors and to develop novel vaccine candidates that may help limit the substantial morbidity and mortality in humans caused by CCHFV."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1715",
            "name": "Recent advances in understanding Crimean–Congo hemorrhagic fever virus"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding Crimean–Congo hemorrhagic fever virus </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17678 data-id=16189 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16189.1" data-recommended="" data-doi="10.12688/f1000research.16189.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1715/v1/pdf?article_uuid=27cff07b-d1b3-4e12-95b6-e1ea53e7709b" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-16189-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-16189-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-16189-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Hawman DW and Feldmann H. Recent advances in understanding Crimean–Congo hemorrhagic fever virus [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1715 (<a class=new-orange href="https://doi.org/10.12688/f1000research.16189.1" target=_blank>https://doi.org/10.12688/f1000research.16189.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-16189-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=16189 id=track-article-signin-16189 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16189?target=/articles/7-1715">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17678 /> <input name=articleId type=hidden value=16189 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding Crimean–Congo hemorrhagic fever virus</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:david.hawman@nih.gov" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>David W. Hawman</span></a>,&nbsp;</span><span class="">Heinz Feldmann<a href="https://orcid.org/0000-0001-9448-8227" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9448-8227</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:david.hawman@nih.gov" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>David W. Hawman</span></a>,&nbsp;</span><span class="">Heinz Feldmann<a href="http://orcid.org/0000-0001-9448-8227" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-9448-8227</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Oct 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.16189.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Laboratory of Virology, Division of Intramural Research, NIAID/NIH, Hamilton, Montana, 59840, USA<br/> <p> <div class=margin-bottom> David W. Hawman <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Heinz Feldmann <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=13615-39628></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=392-39631></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=40559-39630></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=40561-39629></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed hemorrhagic fever virus and the cause of hemorrhagic disease in Africa, Southern and Eastern Europe, the Middle East, India and Asia. Recent emergence of CCHFV into Spain indicates that the geographic range of this virus is expanding and the presence of its tick vector in several countries without reported disease suggest that CCHFV will continue to spread. Research into CCHFV was historically limited by a lack of suitable animal models and tools to study viral pathogenesis. However, in the past few years the toolset for studying CCHFV has expanded with small animal and non-human primate models for CCHFV being developed along with a reverse genetics system that allows for investigation of viral determinants of disease. These tools have been utilized to understand how CCHFV antagonizes host restriction factors and to develop novel vaccine candidates that may help limit the substantial morbidity and mortality in humans caused by CCHFV. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Crimean-Congo hemorrhagic fever virus, CCHFV, CCHF disease, pathogenesis, animal models, vaccines, antivirals </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> David W. Hawman (<a href="mailto:david.hawman@nih.gov">david.hawman@nih.gov</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> David W. Hawman </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This review was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases/National Institutes of Health. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Hawman DW and Feldmann H. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Hawman DW and Feldmann H. Recent advances in understanding Crimean–Congo hemorrhagic fever virus [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1715 (<a href="https://doi.org/10.12688/f1000research.16189.1" target=_blank>https://doi.org/10.12688/f1000research.16189.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Oct 2018, <b>7</b>(F1000 Faculty Rev):1715 (<a href="https://doi.org/10.12688/f1000research.16189.1" target=_blank>https://doi.org/10.12688/f1000research.16189.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Oct 2018, <b>7</b>(F1000 Faculty Rev):1715 (<a href="https://doi.org/10.12688/f1000research.16189.1" target=_blank>https://doi.org/10.12688/f1000research.16189.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d1943e155>Introduction</h2><p class="" id=d1943e158>Crimean–Congo hemorrhagic fever virus (CCHFV) is a negative-sense RNA virus in the <i>Nairoviridae</i> family within the <i>Bunyavirales</i> order of viruses. CCHFV contains three genomic segments: small and medium, which encode for the nucleoprotein and glycoproteins, respectively, and a large segment encoding the RNA-dependent RNA-polymerase. CCHF as a disease was first described in humans in the 1940s when soldiers re-occupying abandoned farmland in the Crimea became ill with a hemorrhagic disease<sup><a href="#ref-1">1</a></sup>. In the late 1960s, it was discovered that the causative agent of this hemorrhagic disease in the Crimea was similar to the causative agent of hemorrhagic disease in the Belgian Congo (current Democratic Republic of the Congo)<sup><a href="#ref-2">2</a></sup>, and the name “Crimean–Congo hemorrhagic fever virus” was ascribed to the pathogen. The main vector and reservoir of CCHFV are hard-body ticks principally of the <i>Hyalomma</i> genus, although there is limited evidence that other species of ticks such as <i>Rhipicephalus</i> and <i>Dermacentor</i> species may be vectors<sup><a href="#ref-3">3</a></sup>. Vertebrate hosts such as domestic livestock and wild animals such as hares likely serve as amplifying hosts of CCHFV, with uninfected ticks becoming infected during feeding on viremic animals or during co-feeding with infected ticks<sup><a href="#ref-4">4</a>–<a href="#ref-6">6</a></sup> (<a href="#f1">Figure 1</a>). The <i>Hyalomma</i> vector is found throughout Africa, Southern and Eastern Europe, the Middle East, India, and Asia and cases of CCHF are reported throughout these regions<sup><a href="#ref-7">7</a></sup>; an estimated 10,000 to 15,000 human infections with CCHFV occur each year, although most of these are subclinical and unrecognized<sup><a href="#ref-7">7</a></sup>. In correlation with the extensive geographic distribution of CCHFV, CCHFV exhibits substantial genetic diversity among geographically distinct isolates; isolates differ at the amino acid level by 5% in the nucleoprotein and L protein and up to 25% in the glycoprotein precursor<sup><a href="#ref-3">3</a></sup>.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/17678/c1cc86d4-61d4-4a6f-8ece-70fa95ea719d_figure1.gif"><img alt="c1cc86d4-61d4-4a6f-8ece-70fa95ea719d_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/17678/c1cc86d4-61d4-4a6f-8ece-70fa95ea719d_figure1.gif"></a><div class=caption><h3>Figure 1. Crimean–Congo hemorrhagic fever virus (CCHFV).</h3><p id=d1943e225>The natural reservoir and vector for CCHFV are ticks of the <i>Hyalomma</i> genus. Ticks can become infected at any life-cycle stage during feeding on a viremic animal or during co-feeding with an infected tick, and mammals likely act as important amplification hosts for the virus. Humans are at risk of CCHFV infection from tick bites, animal husbandry, and butchering of infected livestock and during the care of patients with CCHF. In humans, CCHF first presents as a non-specific febrile illness with a sudden onset of fever, headache, myalgia, and nausea. The disease can rapidly progress to the hemorrhagic phase of disease, during which patients exhibit petechiae, hematomas/ecchymosis, and hemorrhages from various sites around the body. Risk factors for death include elevated inflammatory cytokines and liver enzymes, high viral loads, decreased platelets, and absent antibody responses.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d1943e238>Disease and diagnosis</h2><p class="" id=d1943e241>Humans can become infected with CCHFV via tick bites and butchering of infected livestock and in the health-care setting during the care of infected patients<sup><a href="#ref-8">8</a></sup> (<a href="#f1">Figure 1</a>). Following an incubation period of a few days, the initial symptoms of CCHF are a non-specific febrile illness that can occur suddenly. Sudden onset of fever, myalgia, diarrhea, nausea, and vomiting is typically reported. After this, patients enter the hemorrhagic period in which they begin exhibiting hemorrhages at various sites around the body<sup><a href="#ref-8">8</a></sup>. Case fatality rates can differ between outbreaks but typically range from 5% to 30%<sup><a href="#ref-3">3</a></sup>. However, subclinical or mild cases of CCHF may go unnoticed and may represent a substantial portion of CCHFV infections in humans<sup><a href="#ref-9">9</a></sup>. Despite the known genetic diversity of CCHFV, whether the infecting strain of CCHFV influences disease severity and outcome is unknown. High viral loads, absence of early antibody responses, and high levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are common predictors of poor outcome<sup><a href="#ref-10">10</a>–<a href="#ref-14">14</a></sup> (<a href="#f1">Figure 1</a>). Thrombocytopenia and prolonged clotting times are also seen in severe cases<sup><a href="#ref-12">12</a>,<a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>. Levels of inflammatory cytokines are elevated in severe and fatal CCHF cases<sup><a href="#ref-16">16</a>–<a href="#ref-19">19</a></sup>, suggesting that CCHFV infection induces an inflammatory immune response.</p><p class="" id=d1943e291>The diagnosis of suspected CCHF cases can be accomplished by using reverse transcription–quantitative polymerase chain reaction (RT–qPCR) during the viremic phase of disease. RT–qPCR can also determine viral load, which often is correlated with disease outcome. An important consideration for these assays is the substantial genetic diversity of CCHFV; however, assays that can recognize a multitude of CCHFV genotypes have been developed<sup><a href="#ref-20">20</a>–<a href="#ref-22">22</a></sup>. Enzyme-linked immunosorbent assay and indirect immunofluorescent assay for the detection of human IgM and IgG CCHFV-specific antibodies are approaches of choice for serological diagnosis, and commercial kits are available. These tests may not be appropriate for suspected cases early during the acute phase of disease, as antibody responses are often absent or delayed in serious CCHF cases.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d1943e304>Pathogenesis</h2><p class="" id=d1943e307>Curiously, extensive serological evidence indicates that CCHFV can productively infect numerous vertebrate species, including both wild and domestic animals<sup><a href="#ref-5">5</a></sup>, yet humans seem to be uniquely susceptible to severe or lethal disease. Even within humans, CCHFV infection may result in a mild or subclinical infection<sup><a href="#ref-9">9</a></sup>, and why some patients develop a serious or fatal disease whereas others develop an asymptomatic infection is unknown.</p><p class="" id=d1943e318>The ability of CCHFV to cause severe or lethal disease in mice deficient in the type I interferon system but not wild-type (WT) mice<sup><a href="#ref-23">23</a>–<a href="#ref-25">25</a></sup> suggests that innate immune responses in vertebrate hosts play a substantial role in limiting CCHFV pathogenesis. <i>In vitro</i> studies have identified retinoic acid-inducible gene I (RIG-I) as an innate immune sensor of CCHFV<sup><a href="#ref-26">26</a></sup>, although CCHFV may process its viral RNA to avoid RIG-I sensing<sup><a href="#ref-27">27</a></sup>. However, it is likely that more innate immune sensors contribute to sensing of CCHFV. Retrospective studies in humans have identified correlates between polymorphisms in Toll-like receptors (TLRs) and severity of disease, suggesting that TLRs may be an important immune-sensing pathway in the control of CCHFV. Polymorphisms in TLR7, 8, 9, and 10 have been found to be correlated with disease severity and outcome in infected patients in Turkey<sup><a href="#ref-28">28</a>–<a href="#ref-30">30</a></sup>. Polymorphisms in nuclear factor-kappa B have also been found to correlate with an increased risk of CCHF<sup><a href="#ref-31">31</a></sup>. Whether similar polymorphisms are associated with CCHF and case severity in populations in other geographic regions remains to be determined. Host apoptotic pathways may restrict CCHFV replication, as CCHFV replication can induce apoptosis<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>, and caspase 3, activated during apoptosis, can cleave the CCHFV nucleoprotein and inhibit viral replication<sup><a href="#ref-34">34</a>,<a href="#ref-35">35</a></sup>.</p><p class="" id=d1943e365>CCHFV also antagonizes innate immune signaling. The L segment of CCHFV encodes an ovarian tumor-like deubiquitinase (OTU) domain that recently has been shown to suppress innate immune responses likely by deubiquitinating proteins involved in innate immune signaling pathways<sup><a href="#ref-36">36</a></sup>. The CCHFV OTU domain can also cleave interferon-stimulated gene 15 (ISG15) modifications<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. As ISG15 modifications have been implicated in direct antiviral effects and as ISG15 itself has been found to regulate the host innate immune response to viral infection<sup><a href="#ref-39">39</a></sup>, the de-ISGylation activity of the CCHFV OTU domain may be important for viral pathogenesis. Recombinant CCHFV encoding an OTU deficient in deubiquitinase activity or deficient in both deubiquitinase and de-ISGylation activity had reduced viral growth kinetics compared with WT CCHFV in interferon-competent but not interferon-incompetent cells, demonstrating that the OTU domain is important in overcoming interferon responses<sup><a href="#ref-36">36</a></sup>. Intriguingly, the CCHFV OTU domain has reduced affinity for mouse ISG15 compared with human ISG15, suggesting that mouse ISG15 may be an important barrier to CCHFV infection of mice<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. The CCHFV OTU domain also has higher affinity for human ISG15 than the OTU domains of related <i>Nairoviridae</i> members that are not associated with disease as severe as CCHF, suggesting that the OTU domain may be an important virulence factor for CCHFV<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d1943e402>The role for adaptive immune responses against CCHFV in human pathogenesis is less clear. Low-to-absent anti-CCHFV antibody responses have been found to correlate with severe disease and death<sup><a href="#ref-12">12</a>–<a href="#ref-14">14</a></sup>, and levels of antibody may serve as a predictor of disease outcome. However, whether antibody responses contribute to the control of primary CCHFV infection is unknown, and neutralizing antibody responses even in survivors are typically low<sup><a href="#ref-13">13</a></sup>. Epitope mapping using linear peptides and serum from CCHFV survivors in Turkey and South Africa identified antibody responses toward epitopes in the mucin-like domain, GP38, and Gn protein<sup><a href="#ref-42">42</a></sup> regions that are not likely to result in neutralizing antibodies<sup><a href="#ref-43">43</a></sup>. However, non-neutralizing antibodies were protective against lethal CCHFV challenge<sup><a href="#ref-43">43</a></sup>, demonstrating that antibodies can be protective via mechanisms other than neutralization. Studies evaluating a modified vaccinia virus-based vaccine for CCHFV found protection to require both cellular and humoral responses, suggesting that T cells may be an important component of vaccine-mediated protection against CCHFV<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>. The role for T cells in controlling primary CCHFV infection is unclear. Levels of circulating CD3<sup>+</sup>CD8<sup>+</sup> T cells in peripheral blood were found to positively correlate with fatal outcome<sup><a href="#ref-46">46</a></sup>, and human CCHF survivors have been shown to exhibit long-lived CD8<sup>+</sup> T-cell responses to CCHFV<sup><a href="#ref-47">47</a></sup>. Human leukocyte antigen alleles have also been found to correlate with protection and susceptibility to CCHFV<sup><a href="#ref-48">48</a></sup>. A humanized mouse model of CCHFV demonstrated that T cells were activated following CCHFV infection and CD8<sup>+</sup> T cells had elevated levels of perforin, a marker of cytolytic activity<sup><a href="#ref-49">49</a></sup>. However, further studies are needed to understand how T-cell responses contribute to resolution of the infection.</p><p class="" id=d1943e466>Understanding the role of the adaptive immune response in the control of primary CCHFV infection has been limited by the lack of suitable animal models. Type I interferon-deficient mice exhibit a rapid-onset lethal disease prior to the development of adaptive immune responses, limiting the suitability of this model for studying adaptive immune responses. However, studies in STAT1-deficient mice demonstrated early activation of CD4<sup>+</sup> and CD8<sup>+</sup> T cells, although these cells were depleted from the spleen by day 3 post-infection (PI) and mice succumbed prior to detectable antibody responses<sup><a href="#ref-25">25</a></sup>. In a recent study using mice treated with an interferon blockade antibody, mice deficient in adaptive immune responses, but not WT mice, supported persistent viral replication for at least 2 weeks PI, demonstrating that adaptive immune responses can control CCHFV in mice<sup><a href="#ref-50">50</a></sup>. This model also demonstrated that adaptive immune responses, such as cytolytic T-cell activity, were not necessary for hepatic injury following CCHFV infection<sup><a href="#ref-50">50</a></sup>. These data suggest that CCHFV is directly capable of causing liver damage independent of the host adaptive immune response’s attempts to control viral replication. Furthermore, the recent development of a cynomolgus macaque model of CCHF<sup><a href="#ref-51">51</a></sup> may provide insight into the role of the adaptive immune response and disease outcome. In this model, neither antibody titers nor neutralizing activity of the antibodies correlated with disease outcome<sup><a href="#ref-51">51</a></sup>. However, studies evaluating the contribution of the T-cell response to disease outcome in this model are still needed.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d1943e499>Animal models</h2><p class="" id=d1943e502>For many decades after the discovery and isolation of CCHFV, intracerebrally inoculated neonatal mice were used to propagate and detect CCHFV, as many other commonly used laboratory animals showed no disease following inoculation<sup><a href="#ref-52">52</a></sup>. Currently, the standard mouse model uses mice deficient in type I or both type I and type II interferon responses<sup><a href="#ref-23">23</a>–<a href="#ref-25">25</a></sup> (<a href="#T1">Table 1</a>). Interferon-deficient mice typically exhibit a sudden onset of severe disease followed by death within 4 days PI, and mice exhibit high levels of inflammatory cytokines and elevated liver enzymes at time of death, similar to human CCHFV infections<sup><a href="#ref-23">23</a>–<a href="#ref-25">25</a>,<a href="#ref-53">53</a></sup>. Our lab recently described, in contrast to the sudden onset and death of CCHFV-infected mice in previous models, a model in which type I interferon-deficient mice infected with a clinical isolate, strain Hoti, develop a progressively worsening disease with several days of overt clinical signs followed by death at around day 7 or 8<sup><a href="#ref-54">54</a></sup>. Similarly, low-dose challenge of mice with the clinical isolate Turkey-Kelkit06 strain resulted in a protracted but ultimately fatal disease<sup><a href="#ref-55">55</a></sup>. However, clinical isolates are capable of causing rapidly fatal disease in these mice as demonstrated for the Afg-09 strain<sup><a href="#ref-53">53</a></sup>. These distinct disease progressions of different CCHFV strains in mice suggest that there are important virulence determinants within CCHFV that remain to be described. Furthermore, a mouse model using the interferon blockade antibody MAR1-5A3 has been developed, allowing transient blockade of interferon signaling in a variety of mouse genetic backgrounds<sup><a href="#ref-50">50</a>,<a href="#ref-56">56</a></sup>. This model also allows the vaccination of fully immunocompetent animals that are rendered interferon deficient only at the time of CCHFV challenge, which may improve immune responses to certain vaccines<sup><a href="#ref-56">56</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Animal models of Crimean–Congo hemorrhagic fever virus (CCHFV).</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d1943e564 class=n-a></a><thead><a name=d1943e566 class=n-a></a><tr><a name=d1943e568 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d1943e570 class=n-a></a>Mice</th><th align=left colspan=1 rowspan=1><a name=d1943e573 class=n-a></a>Cynomolgus macaques</th></tr></thead><tbody><a name=d1943e578 class=n-a></a><tr><a name=d1943e580 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d1943e582 class=n-a></a>•&nbsp;&nbsp;&nbsp;Type I interferon-deficient mice<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Either genetic knock out or antibody blockade<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Develop viremia, inflammatory immune responses, liver<br class=br>failure and rapid-onset terminal disease<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multiple CCHFV strains can be used.<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Valuable for studying therapeutic interventions against<br class=br>CCHFV<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Limited for studying host immune responses to CCHFV<br class=br>owing to innate immune deficiencies and death prior to<br class=br>adaptive immune responses<br class=br>•&nbsp;&nbsp;&nbsp;Humanized mice<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mice engrafted with human CD34<sup>+</sup> hematopoietic stem<br class=br>cells<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Develop a neurological-type disease<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Strain-specific virulence observed</td><td align=left colspan=1 rowspan=1 valign=top><a name=d1943e618 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Adult, immunocompetent macaques infected with<br class=br>CCHFV strain Hoti<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Exhibit a spectrum of disease outcomes from<br class=br>asymptomatic to severe, lethal disease<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Develop viremia, inflammatory immune responses,<br class=br>elevated liver enzymes, and increased clotting<br class=br>times<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Major sites of viral replication are liver and spleen<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Valuable pre-clinical model for therapeutic<br class=br>interventions against CCHFV<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Can be used to study host and viral determinants<br class=br>of disease outcome</td></tr></tbody></table></div><p class="" id=d1943e648>Recently, a humanized mouse model was described for CCHFV<sup><a href="#ref-49">49</a></sup>. In this model, irradiated mice are engrafted with human CD34<sup>+</sup> hematopoietic stem cells. This model identified strain-specific virulence with humanized mice infected with a Turkey strain of CCHFV succumbing 2 to 3 weeks PI, whereas mice infected with an Oman strain survived until the study endpoint<sup><a href="#ref-49">49</a></sup>. Interestingly, the mice euthanized for terminal disease following CCHFV Turkey infection were euthanized for neurological manifestations, and high viral loads were found in the brains of euthanized mice<sup><a href="#ref-49">49</a></sup> (<a href="#T1">Table 1</a>).</p><p class="" id=d1943e669>Until recently, there existed no immunocompetent animal model for CCHF. However, our lab recently described a cynomolgus macaque model of CCHF in which cynomolgus macaques infected with a human clinical isolate of CCHFV, strain Hoti, recapitulate many aspects of human CCHF cases<sup><a href="#ref-51">51</a></sup> (<a href="#T1">Table 1</a>). Infected macaques develop a spectrum of disease outcome similar to that of human CCHF cases from asymptomatic to severe or lethal infections. Infected animals developed an early viremia, elevated levels of inflammatory cytokines, thrombocytopenia, and elevated liver enzymes similar to those of human cases of CCHF. Histological analysis showed that CCHFV infection resulted mainly in pathological changes in the liver and spleen, and <i>in situ</i> hybridization demonstrated infection of hepatocytes, Kupffer cells, and endothelial cells of the liver and marginal zone lymphocytes of the spleen and lymph nodes. Although this model is not uniformly lethal, the spectrum of clinical outcome following CCHFV infection within this model provides an opportunity to identify the host and viral mechanisms that contribute to disease outcome.</p><p class="" id=d1943e683>The role of the tick reservoir in CCHFV pathogenesis in vertebrates is largely unknown<sup><a href="#ref-57">57</a></sup>. Current animal studies use needle-delivered mammalian-cell culture-grown CCHFV, which excludes any contribution of tick-derived factors in these models. Tick saliva is capable of modulating a variety of early host defenses<sup><a href="#ref-58">58</a></sup> and may play a role in the early immune responses to CCHFV, as tick saliva inhibited the migration of antigen-presenting cells <i>in vitro</i><sup><a href="#ref-59">59</a></sup>. A tick transmission model involving infected ticks feeding on mice has recently shown that CCHFV genetic diversity may be shaped by the tick reservoir rather than the vertebrate hosts<sup><a href="#ref-60">60</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d1943e707>Vaccines</h2><p class="" id=d1943e710>Currently, the only vaccine for CCHFV is an inactivated preparation of virus grown in neonatal mouse brains<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>; however, this vaccine is used only in Bulgaria and is not approved for use in other countries with at-risk populations. The scalability and safety concerns of this type of vaccine will likely prevent widespread deployment of this vaccine, and new vaccine platforms for CCHFV are needed. An international collaboration among CCHFV researchers has been started to develop CCHFV vaccines and bring them to the clinic (<a target=xrefwindow href="http://www.cchfvaccine.eu/" id=d1943e719>http://www.cchfvaccine.eu/</a>), and several vaccines have shown promise in pre-clinical trials. A modified vaccinia virus expressing the glycoproteins of CCHFV was shown to provide 100% protection to lethally challenged mice<sup><a href="#ref-44">44</a></sup>. DNA-based vaccination or virus-like particle vaccination has also been shown to confer protection against lethal CCHFV challenge<sup><a href="#ref-56">56</a>,<a href="#ref-63">63</a></sup>. Mice fed transgenic plants expressing the CCHFV glycoproteins developed antibodies against the glycoproteins<sup><a href="#ref-64">64</a></sup>, although the efficacy of this platform against CCHFV challenge was not tested. Interestingly, although subunit vaccines containing the glycoproteins are immunogenic in mice<sup><a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>, they may not induce protective immune responses to CCHFV challenge<sup><a href="#ref-65">65</a></sup>. A formalin-inactivated preparation of CCHFV was also found to be protective against CCHFV infection in mice<sup><a href="#ref-55">55</a></sup>.</p><p class="" id=d1943e754>In addition to the glycoproteins, the nucleoprotein of CCHFV, encoded by the S segment, has been targeted by vaccines either on its own<sup><a href="#ref-67">67</a>,<a href="#ref-68">68</a></sup> or in combination platforms that include both the nucleoprotein and the glycoproteins<sup><a href="#ref-63">63</a></sup>. Notably, vaccination with an adenovirus expressing the nucleoprotein of CCHFV provided substantial protection against lethal CCHFV challenge in mice<sup><a href="#ref-67">67</a></sup>, demonstrating that immune responses directed against the nucleoprotein can be protective independently of responses to the glycoproteins. However, a modified vaccinia virus expressing the nucleoprotein of CCHFV, though immunogenic, failed to protect against lethal CCHFV challenge<sup><a href="#ref-68">68</a></sup>, suggesting that protection afforded by nucleoprotein-based vaccines may be incomplete. Nevertheless, the greater sequence conservation of the nucleoprotein, even among divergent CCHFV strains, suggests that the nucleoprotein may be worth including in vaccine preparations to generate broadly protective immune responses.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d1943e780>Antivirals</h2><p class="" id=d1943e783>In addition to vaccines, investigations of antivirals against CCHFV have been conducted. Ribavirin, a nucleoside analog, is suggested by the World Health Organization for the treatment of CCHFV. However, clinical data supporting the use of ribavirin to treat CCHF are inconsistent; some studies report benefits whereas others report no benefit, and meta-analyses of multiple studies suggest that the efficacy of ribavirin is poor or inconclusive<sup><a href="#ref-69">69</a>–<a href="#ref-71">71</a></sup>. Notably, a placebo-controlled study failed to identify a clinical benefit of ribavirin treatment in patients with CCHF<sup><a href="#ref-72">72</a></sup>. A recent meta-analysis demonstrated that ribavirin treatment needs to be started soon after symptom onset (&lt;48 hours) to reduce odds of death<sup><a href="#ref-73">73</a></sup>. In the recent emergence of CCHFV in Spain, although treatment of an infected nurse with ribavirin had mutagenic effects on CCHFV <i>in vivo</i> and a reduction in viral titers was coincident with treatment start<sup><a href="#ref-74">74</a></sup>, ultimately ribavirin treatment was discontinued because of suspected hemolytic anemia<sup><a href="#ref-75">75</a></sup>, a potential complication of ribavirin treatment<sup><a href="#ref-76">76</a>,<a href="#ref-77">77</a></sup>. The inconsistent data on the clinical benefit of ribavirin for the treatment of CCHFV and the potential for adverse events with ribavirin treatment have caused significant debate in the field<sup><a href="#ref-78">78</a>–<a href="#ref-81">81</a></sup>. Ethical considerations of placebo-controlled studies will likely make further studies of this type difficult<sup><a href="#ref-82">82</a></sup>, preventing definitive conclusions on the efficacy of ribavirin in patients with CCHF.</p><p class="" id=d1943e831>Studies in mouse models have also shown inconsistent efficacy of ribavirin. Two studies have shown that even early treatment with ribavirin (&lt;6 hours PI) was unable to prevent lethal disease following infection with two distinct clinical isolates of CCHFV<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>. However, another study showed that ribavirin could protect against lethal disease following CCHFV strain 10200 infection when administered early and that protection diminished when treatment was delayed or challenge dose was increased<sup><a href="#ref-25">25</a></sup>. However, results from our lab showed that although early ribavirin treatment extended the mean time to death, ribavirin was unable to prevent death in 10200-infected mice<sup><a href="#ref-54">54</a></sup>. The reason for the distinct outcomes in ribavirin-treated strain 10200-infected mice seen between our study<sup><a href="#ref-54">54</a></sup> and that by Bente <i>et al</i>.<sup><a href="#ref-25">25</a></sup> is unknown but could be due to differences in mouse strain (IFNAR<sup>−/−</sup> versus STAT1<sup>−/−</sup>), challenge dose, or the time treatment was started after infection. Cumulatively, data in humans and mice suggest that while ribavirin may have limited clinical benefit in patients with CCHF, treatment likely needs to be started early in the course of disease to have clinical benefit. This may prove difficult, as the early symptoms of CCHF are non-specific and can progress rapidly to severe, hemorrhagic manifestations<sup><a href="#ref-8">8</a></sup> and therefore patients may not present to health-care providers until exhibiting the more serious symptoms of CCHF.</p><p class="" id=d1943e871>Favipiravir is approved in Japan for the treatment of influenza virus infections<sup><a href="#ref-83">83</a></sup> but has shown promise against other highly pathogenic RNA viruses, including Ebola<sup><a href="#ref-84">84</a></sup> and Lassa<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>. Two studies have evaluated favipiravir against CCHFV <i>in vivo</i>. In a study by Oestereich <i>et al</i>., favipiravir treatment was effective in suppressing viral replication and preventing mortality following CCHFV infection, even when treatment was started 48 hours PI<sup><a href="#ref-53">53</a></sup>. Similarly, work by our group has shown that favipiravir treatment could be delayed until 6 days PI, a time point at which mice were exhibiting advanced disease, including death, and still offer significant clinical benefit to CCHFV-infected mice<sup><a href="#ref-54">54</a></sup>. These data suggest that favipiravir may be an effective antiviral for the treatment of advanced CCHF. Furthermore, Oestereich <i>et al</i>. demonstrated that favipiravir and ribavirin could synergistically inhibit CCHFV <i>in vitro</i>, allowing lower doses of both drugs to be used <i>in vivo</i> with clinical efficacy, suggesting that combination therapies in humans may be effective in treating CCHF while reducing unwanted side effects<sup><a href="#ref-53">53</a></sup>. A similar approach has been used in Lassa fever cases<sup><a href="#ref-87">87</a></sup>. In addition, a high-throughput screen using recombinant CCHFV identified a compound, 2′-deoxy-2′-fluorocytidine, with inhibitory activity superior to that of favipiravir or ribavirin <i>in vitro</i><sup><a href="#ref-88">88</a></sup>. <i>In vivo</i> animal studies will be needed to evaluate how this compound performs in animal models of CCHF. Lastly, monoclonal antibodies have shown efficacy against CCHFV <i>in vivo</i><sup><a href="#ref-43">43</a></sup>, and several clones were shown to neutralize divergent CCHFV strains<sup><a href="#ref-89">89</a></sup>, suggesting that they may have promise for the treatment of CCHF.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d1943e944>Summary</h2><p class="" id=d1943e947>In conclusion, much remains to be understood about the pathogenesis of CCHFV. However, the toolset for studying CCHFV has been steadily improving in recent years with the development of mouse and non-human primate models to a reverse genetics system for CCHFV that will facilitate dissection of the host and viral determinants of CCHFV pathogenesis. These tools will also allow the development and evaluation of novel therapies that reduce or prevent CCHFV-induced morbidity and mortality. Hopefully, the collaboration of multiple institutions in countries around the world toward the development of vaccines against CCHFV will lead to safe and effective vaccines for CCHFV being deployed in populations at risk for CCHFV infection. Lastly, the role of the tick vector in transmission and pathogenesis needs more attention, as does the role of livestock and other animal species in maintaining and transmitting CCHFV. This could lead to more effective measures to block CCHFV transmission.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d1943e1 class=n-a></a><h2 class=main-title id=d2213>Grant information</h2><p>This review was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases/National Institutes of Health.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d1943e954 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d2524>References</h2><div class="section ref-list"><a name=d1943e954 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d1943e961 class=n-a></a>Hoogstraal H: The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. <i>J Med Entomol.</i> 1979; <b>15</b>(4): 307–417. <a target=xrefwindow id=d1943e969 href="http://www.ncbi.nlm.nih.gov/pubmed/113533">PubMed Abstract </a> | <a target=xrefwindow id=d1943e972 href="https://doi.org/10.1093/jmedent/15.4.307">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d1943e981 class=n-a></a>Casals J: Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus. <i>Proc Soc Exp Biol Med.</i> 1969; <b>131</b>(1): 233–6. <a target=xrefwindow id=d1943e989 href="http://www.ncbi.nlm.nih.gov/pubmed/5770109">PubMed Abstract </a> | <a target=xrefwindow id=d1943e992 href="https://doi.org/10.3181/00379727-131-33847">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718057860"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1001 class=n-a></a>Bente DA, Forrester NL, Watts DM, <i> et al.</i>: Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. <i>Antiviral Res.</i> 2013; <b>100</b>(1): 159–89. <a target=xrefwindow id=d1943e1012 href="http://www.ncbi.nlm.nih.gov/pubmed/23906741">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1015 href="https://doi.org/10.1016/j.antiviral.2013.07.006">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718057860">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734136109"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1028 class=n-a></a>Gargili A, Estrada-Peña A, Spengler JR, <i> et al.</i>: The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus: A review of published field and laboratory studies. <i>Antiviral Res.</i> 2017; <b>144</b>: 93–119. <a target=xrefwindow id=d1943e1039 href="http://www.ncbi.nlm.nih.gov/pubmed/28579441">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1042 href="https://doi.org/10.1016/j.antiviral.2017.05.010">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1046 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6047067">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734136109">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726060970"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1059 class=n-a></a>Spengler JR, Bergeron É, Rollin PE: Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals. <i>PLoS Negl Trop Dis.</i> 2016; <b>10</b>(1): e0004210. <a target=xrefwindow id=d1943e1067 href="http://www.ncbi.nlm.nih.gov/pubmed/26741652">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1070 href="https://doi.org/10.1371/journal.pntd.0004210">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1073 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4704823">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726060970">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d1943e1087 class=n-a></a>Gordon SW, Linthicum KJ, Moulton JR: Transmission of Crimean-Congo hemorrhagic fever virus in two species of <i>Hyalomma</i> ticks from infected adults to cofeeding immature forms. <i>Am J Trop Med Hyg.</i> 1993; <b>48</b>(4): 576–80. <a target=xrefwindow id=d1943e1098 href="http://www.ncbi.nlm.nih.gov/pubmed/8480867">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1101 href="https://doi.org/10.4269/ajtmh.1993.48.576">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d1943e1110 class=n-a></a>Crimean-Congo haemorrhagic fever. 2017. <a target=xrefwindow id=d1943e1112 href="http://www.who.int/emergencies/diseases/crimean-congo-haemorrhagic-fever/en/">Reference Source</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d1943e1121 class=n-a></a>Ergönül O: Crimean-Congo haemorrhagic fever. <i>Lancet Infect Dis.</i> 2006; <b>6</b>(4): 203–14. <a target=xrefwindow id=d1943e1129 href="http://www.ncbi.nlm.nih.gov/pubmed/16554245">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1132 href="https://doi.org/10.1016/S1473-3099(06)70435-2">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720418648"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1141 class=n-a></a>Bodur H, Akinci E, Ascioglu S, <i> et al.</i>: Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. <i>Emerg Infect Dis.</i> 2012; <b>18</b>(4): 640–2. <a target=xrefwindow id=d1943e1152 href="http://www.ncbi.nlm.nih.gov/pubmed/22469474">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1155 href="https://doi.org/10.3201/eid1804.111374">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1159 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3309668">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720418648">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728928982"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1172 class=n-a></a>Hasanoglu I, Guner R, Carhan A, <i> et al.</i>: Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load. <i>J Clin Virol.</i> 2016; <b>75</b>: 42–6. <a target=xrefwindow id=d1943e1183 href="http://www.ncbi.nlm.nih.gov/pubmed/26780111">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1186 href="https://doi.org/10.1016/j.jcv.2015.12.006">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728928982">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d1943e1199 class=n-a></a>Duh D, Saksida A, Petrovec M, <i> et al.</i>: Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. <i>Emerg Infect Dis.</i> 2007; <b>13</b>(11): 1769–72. <a target=xrefwindow id=d1943e1210 href="http://www.ncbi.nlm.nih.gov/pubmed/18217568">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1213 href="https://doi.org/10.3201/eid1311.070222">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1217 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3375790">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d1943e1227 class=n-a></a>Ergonul O, Celikbas A, Baykam N, <i> et al.</i>: Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: Severity criteria revisited. <i>Clin Microbiol Infect.</i> 2006; <b>12</b>(6): 551–4. <a target=xrefwindow id=d1943e1238 href="http://www.ncbi.nlm.nih.gov/pubmed/16700704">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1241 href="https://doi.org/10.1111/j.1469-0691.2006.01445.x">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d1943e1250 class=n-a></a>Shepherd AJ, Swanepoel R, Leman PA: Antibody response in Crimean-Congo hemorrhagic fever. <i>Rev Infect Dis.</i> 1989; <b>11 Suppl 4</b>: S801–S806. <a target=xrefwindow id=d1943e1258 href="http://www.ncbi.nlm.nih.gov/pubmed/2501854">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1261 href="https://doi.org/10.1093/clinids/11.Supplement_4.S801">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d1943e1270 class=n-a></a>Swanepoel R, Gill DE, Shepherd AJ, <i> et al.</i>: The clinical pathology of Crimean-Congo hemorrhagic fever. <i>Rev Infect Dis.</i> 1989; <b>11 Suppl 4</b>: S794–S800. <a target=xrefwindow id=d1943e1281 href="http://www.ncbi.nlm.nih.gov/pubmed/2749111">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1284 href="https://doi.org/10.1093/clinids/11.Supplement_4.S794">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d1943e1293 class=n-a></a>Cevik MA, Erbay A, Bodur H, <i> et al.</i>: Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. <i>Int J Infect Dis.</i> 2008; <b>12</b>(4): 374–9. <a target=xrefwindow id=d1943e1304 href="http://www.ncbi.nlm.nih.gov/pubmed/18063402">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1307 href="https://doi.org/10.1016/j.ijid.2007.09.010">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d1943e1316 class=n-a></a>Ergonul O, Tuncbilek S, Baykam N, <i> et al.</i>: Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. <i>J Infect Dis.</i> 2006; <b>193</b>(7): 941–4. <a target=xrefwindow id=d1943e1327 href="http://www.ncbi.nlm.nih.gov/pubmed/16518755">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1330 href="https://doi.org/10.1086/500836">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d1943e1339 class=n-a></a>Papa A, Bino S, Velo E, <i> et al.</i>: Cytokine levels in Crimean-Congo hemorrhagic fever. <i>J Clin Virol.</i> 2006; <b>36</b>(4): 272–6. <a target=xrefwindow id=d1943e1350 href="http://www.ncbi.nlm.nih.gov/pubmed/16765637">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1353 href="https://doi.org/10.1016/j.jcv.2006.04.007">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d1943e1363 class=n-a></a>Kaya S, Elaldi N, Kubar A, <i> et al.</i>: Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever. <i>BMC Infect Dis.</i> 2014; <b>14</b>: 416. <a target=xrefwindow id=d1943e1374 href="http://www.ncbi.nlm.nih.gov/pubmed/25066751">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1377 href="https://doi.org/10.1186/1471-2334-14-416">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1381 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4133611">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729024122"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1390 class=n-a></a>Papa A, Tsergouli K, Çağlayık DY, <i> et al.</i>: Cytokines as biomarkers of Crimean-Congo hemorrhagic fever. <i>J Med Virol.</i> 2016; <b>88</b>(1): 21–7. <a target=xrefwindow id=d1943e1401 href="http://www.ncbi.nlm.nih.gov/pubmed/26118413">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1404 href="https://doi.org/10.1002/jmv.24312">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729024122">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d1943e1417 class=n-a></a>Sas MA, Vina-Rodriguez A, Mertens M, <i> et al.</i>: A one-step multiplex real-time RT-PCR for the universal detection of all currently known CCHFV genotypes. <i>J Virol Methods.</i> 2018; <b>255</b>: 38–43. <a target=xrefwindow id=d1943e1428 href="http://www.ncbi.nlm.nih.gov/pubmed/29408661">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1431 href="https://doi.org/10.1016/j.jviromet.2018.01.013">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d1943e1440 class=n-a></a>Atkinson B, Chamberlain J, Logue CH, <i> et al.</i>: Development of a real-time RT-PCR assay for the detection of Crimean-Congo hemorrhagic fever virus. <i>Vector Borne Zoonotic Dis.</i> 2012; <b>12</b>(9): 786–93. <a target=xrefwindow id=d1943e1451 href="http://www.ncbi.nlm.nih.gov/pubmed/22217175">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1454 href="https://doi.org/10.1089/vbz.2011.0770">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d1943e1463 class=n-a></a>Jääskeläinen AJ, Kallio-Kokko H, Ozkul A, <i> et al.</i>: Development and evaluation of a real-time RT-qPCR for detection of Crimean-Congo hemorrhagic fever virus representing different genotypes. <i>Vector Borne Zoonotic Dis.</i> 2014; <b>14</b>(12): 870–2. <a target=xrefwindow id=d1943e1474 href="http://www.ncbi.nlm.nih.gov/pubmed/25514124">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1477 href="https://doi.org/10.1089/vbz.2014.1577">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1481 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4270107">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d1943e1490 class=n-a></a>Zivcec M, Safronetz D, Scott D, <i> et al.</i>: Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. <i>J Infect Dis.</i> 2013; <b>207</b>(12): 1909–21. <a target=xrefwindow id=d1943e1501 href="http://www.ncbi.nlm.nih.gov/pubmed/23417661">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1504 href="https://doi.org/10.1093/infdis/jit061">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1508 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3654741">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d1943e1518 class=n-a></a>Bereczky S, Lindegren G, Karlberg H, <i> et al.</i>: Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. <i>J Gen Virol.</i> 2010; <b>91</b>(Pt 6): 1473–7. <a target=xrefwindow id=d1943e1529 href="http://www.ncbi.nlm.nih.gov/pubmed/20164263">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1532 href="https://doi.org/10.1099/vir.0.019034-0">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d1943e1541 class=n-a></a>Bente DA, Alimonti JB, Shieh WJ, <i> et al.</i>: Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. <i>J Virol.</i> 2010; <b>84</b>(21): 11089–100. <a target=xrefwindow id=d1943e1552 href="http://www.ncbi.nlm.nih.gov/pubmed/20739514">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1555 href="https://doi.org/10.1128/JVI.01383-10">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1559 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2953203">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d1943e1568 class=n-a></a>Spengler JR, Patel JR, Chakrabarti AK, <i> et al.</i>: RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus. <i>J Virol.</i> 2015; <b>89</b>(20): 10219–29. <a target=xrefwindow id=d1943e1579 href="http://www.ncbi.nlm.nih.gov/pubmed/26223644">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1582 href="https://doi.org/10.1128/JVI.01643-15">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1586 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4580164">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1108125"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1595 class=n-a></a>Habjan M, Andersson I, Klingström J, <i> et al.</i>: Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. <i>PLoS One.</i> 2008; <b>3</b>(4): e2032. <a target=xrefwindow id=d1943e1606 href="http://www.ncbi.nlm.nih.gov/pubmed/18446221">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1609 href="https://doi.org/10.1371/journal.pone.0002032">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1613 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2323571">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1108125">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d1943e1626 class=n-a></a>Arslan S, Engin A, Özbilüm N, <i> et al.</i>: Toll-like receptor 7 Gln11Leu, c.4-151A/G, and +1817G/T polymorphisms in Crimean Congo hemorrhagic fever. <i>J Med Virol.</i> 2015; <b>87</b>(7): 1090–5. <a target=xrefwindow id=d1943e1637 href="http://www.ncbi.nlm.nih.gov/pubmed/25879168">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1640 href="https://doi.org/10.1002/jmv.24174">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d1943e1649 class=n-a></a>Engin A, Arslan S, Kizildag S, <i> et al.</i>: Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. <i>Microbes Infect.</i> 2010; <b>12</b>(12–13): 1071–8. <a target=xrefwindow id=d1943e1660 href="http://www.ncbi.nlm.nih.gov/pubmed/20674764">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1663 href="https://doi.org/10.1016/j.micinf.2010.07.012">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d1943e1673 class=n-a></a>Kızıldağ S, Arslan S, Özbilüm N, <i> et al.</i>: Effect of TLR10 (2322A/G, 720A/C, and 992T/A) polymorphisms on the pathogenesis of Crimean Congo hemorrhagic fever disease. <i>J Med Virol.</i> 2018; <b>90</b>(1): 19–25. <a target=xrefwindow id=d1943e1684 href="http://www.ncbi.nlm.nih.gov/pubmed/28843003">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1687 href="https://doi.org/10.1002/jmv.24924">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d1943e1696 class=n-a></a>Arslan S, Engin A: Relationship between NF-κB1 and NF-κBIA genetic polymorphisms and Crimean-Congo hemorrhagic fever. <i>Scand J Infect Dis.</i> 2012; <b>44</b>(2): 138–43. <a target=xrefwindow id=d1943e1704 href="http://www.ncbi.nlm.nih.gov/pubmed/22066734">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1707 href="https://doi.org/10.3109/00365548.2011.623313">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725940761"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1716 class=n-a></a>Barnwal B, Karlberg H, Mirazimi A, <i> et al.</i>: The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis. <i>J Biol Chem.</i> 2016; <b>291</b>(2): 582–92. <a target=xrefwindow id=d1943e1727 href="http://www.ncbi.nlm.nih.gov/pubmed/26574543">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1730 href="https://doi.org/10.1074/jbc.M115.667436">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1734 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4705379">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725940761">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d1943e1747 class=n-a></a>Rodrigues R, Paranhos-Baccalà G, Vernet G, <i> et al.</i>: Crimean-Congo hemorrhagic fever virus-infected hepatocytes induce ER-stress and apoptosis crosstalk. <i>PLoS One.</i> 2012; <b>7</b>(1): e29712. <a target=xrefwindow id=d1943e1758 href="http://www.ncbi.nlm.nih.gov/pubmed/22238639">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1761 href="https://doi.org/10.1371/journal.pone.0029712">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1765 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3253088">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d1943e1774 class=n-a></a>Karlberg H, Tan YJ, Mirazimi A: Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. <i>J Biol Chem.</i> 2011; <b>286</b>(5): 3227–34. <a target=xrefwindow id=d1943e1782 href="http://www.ncbi.nlm.nih.gov/pubmed/21123175">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1785 href="https://doi.org/10.1074/jbc.M110.149369">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1788 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3030327">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d1943e1797 class=n-a></a>Wang Y, Dutta S, Karlberg H, <i> et al.</i>: Structure of Crimean-Congo hemorrhagic fever virus nucleoprotein: superhelical homo-oligomers and the role of caspase-3 cleavage. <i>J Virol.</i> 2012; <b>86</b>(22): 12294–303. <a target=xrefwindow id=d1943e1808 href="http://www.ncbi.nlm.nih.gov/pubmed/22951837">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1811 href="https://doi.org/10.1128/JVI.01627-12">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1815 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3486442">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730845085"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1825 class=n-a></a>Scholte FEM, Zivcec M, Dzimianski JV, <i> et al.</i>: Crimean-Congo Hemorrhagic Fever Virus Suppresses Innate Immune Responses via a Ubiquitin and ISG15 Specific Protease. <i>Cell Rep.</i> 2017; <b>20</b>(10): 2396–407. <a target=xrefwindow id=d1943e1836 href="http://www.ncbi.nlm.nih.gov/pubmed/28877473">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1839 href="https://doi.org/10.1016/j.celrep.2017.08.040">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1843 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5616139">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730845085">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1098596"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1856 class=n-a></a>Frias-Staheli N, Giannakopoulos NV, Kikkert M, <i> et al.</i>: Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. <i>Cell Host Microbe.</i> 2007; <b>2</b>(6): 404–16. <a target=xrefwindow id=d1943e1867 href="http://www.ncbi.nlm.nih.gov/pubmed/18078692">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1870 href="https://doi.org/10.1016/j.chom.2007.09.014">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1874 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2184509">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1098596">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d1943e1887 class=n-a></a>James TW, Frias-Staheli N, Bacik JP, <i> et al.</i>: Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(6): 2222–7. <a target=xrefwindow id=d1943e1898 href="http://www.ncbi.nlm.nih.gov/pubmed/21245344">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1901 href="https://doi.org/10.1073/pnas.1013388108">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1905 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3038750">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733253914"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1914 class=n-a></a>Perng YC, Lenschow DJ: ISG15 in antiviral immunity and beyond. <i>Nat Rev Microbiol.</i> 2018; <b>16</b>(7): 423–39. <a target=xrefwindow id=d1943e1922 href="http://www.ncbi.nlm.nih.gov/pubmed/29769653">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1925 href="https://doi.org/10.1038/s41579-018-0020-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733253914">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d1943e1938 class=n-a></a>Capodagli GC, Deaton MK, Baker EA, <i> et al.</i>: Diversity of ubiquitin and ISG15 specificity among nairoviruses' viral ovarian tumor domain proteases. <i>J Virol.</i> 2013; <b>87</b>(7): 3815–27. <a target=xrefwindow id=d1943e1949 href="http://www.ncbi.nlm.nih.gov/pubmed/23345508">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1952 href="https://doi.org/10.1128/JVI.03252-12">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1956 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3624237">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726505485"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e1965 class=n-a></a>Deaton MK, Dzimianski JV, Daczkowski CM, <i> et al.</i>: Biochemical and Structural Insights into the Preference of Nairoviral DeISGylases for Interferon-Stimulated Gene Product 15 Originating from Certain Species. <i>J Virol.</i> 2016; <b>90</b>(18): 8314–27. <a target=xrefwindow id=d1943e1976 href="http://www.ncbi.nlm.nih.gov/pubmed/27412597">PubMed Abstract </a> | <a target=xrefwindow id=d1943e1979 href="https://doi.org/10.1128/JVI.00975-16">Publisher Full Text </a> | <a target=xrefwindow id=d1943e1983 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5008091">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726505485">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d1943e1997 class=n-a></a>Fritzen A, Risinger C, Korukluoglu G, <i> et al.</i>: Epitope-mapping of the glycoprotein from Crimean-Congo hemorrhagic fever virus using a microarray approach. <i>PLoS Negl Trop Dis.</i> 2018; <b>12</b>(7): e0006598. <a target=xrefwindow id=d1943e2008 href="http://www.ncbi.nlm.nih.gov/pubmed/29985929">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2011 href="https://doi.org/10.1371/journal.pntd.0006598">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2015 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6053253">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d1943e2024 class=n-a></a>Bertolotti-Ciarlet A, Smith J, Strecker K, <i> et al.</i>: Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins. <i>J Virol.</i> 2005; <b>79</b>(10): 6152–61. <a target=xrefwindow id=d1943e2035 href="http://www.ncbi.nlm.nih.gov/pubmed/15858000">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2038 href="https://doi.org/10.1128/JVI.79.10.6152-6161.2005">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2042 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1091677">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d1943e2051 class=n-a></a>Buttigieg KR, Dowall SD, Findlay-Wilson S, <i> et al.</i>: A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model. <i>PLoS One.</i> 2014; <b>9</b>(3): e91516. <a target=xrefwindow id=d1943e2062 href="http://www.ncbi.nlm.nih.gov/pubmed/24621656">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2065 href="https://doi.org/10.1371/journal.pone.0091516">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2069 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3951450">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726406288"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2078 class=n-a></a>Dowall SD, Graham VA, Rayner E, <i> et al.</i>: Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses. <i>PLoS One.</i> 2016; <b>11</b>(6): e0156637. <a target=xrefwindow id=d1943e2089 href="http://www.ncbi.nlm.nih.gov/pubmed/27272940">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2092 href="https://doi.org/10.1371/journal.pone.0156637">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2096 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4896484">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726406288">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d1943e2109 class=n-a></a>Akinci E, Yilmaz M, Bodur H, <i> et al.</i>: Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever. <i>Int J Infect Dis.</i> 2009; <b>13</b>(5): 560–3. <a target=xrefwindow id=d1943e2120 href="http://www.ncbi.nlm.nih.gov/pubmed/19112036">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2123 href="https://doi.org/10.1016/j.ijid.2008.08.027">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732331738"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2132 class=n-a></a>Goedhals D, Paweska JT, Burt FJ: Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection. <i>PLoS Negl Trop Dis.</i> 2017; <b>11</b>(12): e0006149. <a target=xrefwindow id=d1943e2140 href="http://www.ncbi.nlm.nih.gov/pubmed/29261651">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2143 href="https://doi.org/10.1371/journal.pntd.0006149">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2146 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5752039">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732331738">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d1943e2160 class=n-a></a>Akıncı E, Bodur H, Muşabak U, <i> et al.</i>: The relationship between the human leukocyte antigen system and Crimean-Congo hemorrhagic fever in the Turkish population. <i>Int J Infect Dis.</i> 2013; <b>17</b>(11): e1038–41. <a target=xrefwindow id=d1943e2171 href="http://www.ncbi.nlm.nih.gov/pubmed/23911239">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2174 href="https://doi.org/10.1016/j.ijid.2013.06.005">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727593597"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2183 class=n-a></a>Spengler JR, Kelly Keating M, McElroy AK, <i> et al.</i>: Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection. <i>J Infect Dis.</i> 2017; <b>216</b>(11): 1386–97. <a target=xrefwindow id=d1943e2194 href="http://www.ncbi.nlm.nih.gov/pubmed/28482001">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2197 href="https://doi.org/10.1093/infdis/jix215">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2201 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5853341">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727593597">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733826164"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2214 class=n-a></a>Lindquist ME, Zeng X, Altamura LA, <i> et al.</i>: Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice. <i>J Virol.</i> 2018; <b>92</b>(21): pii: e01083-18. <a target=xrefwindow id=d1943e2225 href="http://www.ncbi.nlm.nih.gov/pubmed/30111561">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2228 href="https://doi.org/10.1128/JVI.01083-18">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733826164">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d1943e2241 class=n-a></a>Haddock E, Feldmann F, Hawman DW, <i> et al.</i>: A cynomolgus macaque model for Crimean-Congo haemorrhagic fever. <i>Nat Microbiol.</i> 2018; <b>3</b>(5): 556–62. <a target=xrefwindow id=d1943e2252 href="http://www.ncbi.nlm.nih.gov/pubmed/29632370">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2255 href="https://doi.org/10.1038/s41564-018-0141-7">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d1943e2264 class=n-a></a>Smirnova SE: A comparative study of the Crimean hemorrhagic fever-Congo group of viruses. <i>Arch Virol.</i> 1979; <b>62</b>(2): 137–43. <a target=xrefwindow id=d1943e2272 href="http://www.ncbi.nlm.nih.gov/pubmed/94536">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2275 href="https://doi.org/10.1007/BF01318066">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d1943e2284 class=n-a></a>Oestereich L, Rieger T, Neumann M, <i> et al.</i>: Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. <i>PLoS Negl Trop Dis.</i> 2014; <b>8</b>(5): e2804. <a target=xrefwindow id=d1943e2295 href="http://www.ncbi.nlm.nih.gov/pubmed/24786461">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2298 href="https://doi.org/10.1371/journal.pntd.0002804">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2302 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4006714">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d1943e2312 class=n-a></a>Hawman DW, Haddock E, Meade-White K, <i> et al.</i>: Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. <i>Antiviral Res.</i> 2018; <b>157</b>: 18–26. <a target=xrefwindow id=d1943e2323 href="http://www.ncbi.nlm.nih.gov/pubmed/29936152">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2326 href="https://doi.org/10.1016/j.antiviral.2018.06.013">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d1943e2335 class=n-a></a>Canakoglu N, Berber E, Tonbak S, <i> et al.</i>: Immunization of knock-out α/β interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine. <i>PLoS Negl Trop Dis.</i> 2015; <b>9</b>(3): e0003579. <a target=xrefwindow id=d1943e2346 href="http://www.ncbi.nlm.nih.gov/pubmed/25760444">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2349 href="https://doi.org/10.1371/journal.pntd.0003579">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2353 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4356576">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d1943e2362 class=n-a></a>Garrison AR, Shoemaker CJ, Golden JW, <i> et al.</i>: A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. <i>PLoS Negl Trop Dis.</i> 2017; <b>11</b>(9): e0005908. <a target=xrefwindow id=d1943e2373 href="http://www.ncbi.nlm.nih.gov/pubmed/28922426">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2376 href="https://doi.org/10.1371/journal.pntd.0005908">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2380 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5619839">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d1943e2389 class=n-a></a>Papa A, Tsergouli K, Tsioka K, <i> et al.</i>: Crimean-Congo Hemorrhagic Fever: Tick-Host-Virus Interactions. <i>Front Cell Infect Microbiol.</i> 2017; <b>7</b>: 213. <a target=xrefwindow id=d1943e2400 href="http://www.ncbi.nlm.nih.gov/pubmed/28603698">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2403 href="https://doi.org/10.3389/fcimb.2017.00213">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2407 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5445422">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d1943e2416 class=n-a></a>Šimo L, Kazimirova M, Richardson J, <i> et al.</i>: The Essential Role of Tick Salivary Glands and Saliva in Tick Feeding and Pathogen Transmission. <i>Front Cell Infect Microbiol.</i> 2017; <b>7</b>: 281. <a target=xrefwindow id=d1943e2427 href="http://www.ncbi.nlm.nih.gov/pubmed/28690983">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2430 href="https://doi.org/10.3389/fcimb.2017.00281">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2434 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5479950">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733689488"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2443 class=n-a></a>Rodriguez SE, McAuley AJ, Gargili A, <i> et al.</i>: Interactions of Human Dermal Dendritic Cells and Langerhans Cells Treated with <i>Hyalomma</i> Tick Saliva with Crimean-Congo Hemorrhagic Fever Virus. <i>Viruses.</i> 2018; <b>10</b>(7): pii: E381. <a target=xrefwindow id=d1943e2457 href="http://www.ncbi.nlm.nih.gov/pubmed/30036960">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2461 href="https://doi.org/10.3390/v10070381">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2464 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6070959">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733689488">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726881001"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2478 class=n-a></a>Xia H, Beck AS, Gargili A, <i> et al.</i>: Transstadial Transmission and Long-term Association of Crimean-Congo Hemorrhagic Fever Virus in Ticks Shapes Genome Plasticity. <i>Sci Rep.</i> 2016; <b>6</b>: 35819. <a target=xrefwindow id=d1943e2489 href="http://www.ncbi.nlm.nih.gov/pubmed/27775001">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2492 href="https://doi.org/10.1038/srep35819">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5075774">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726881001">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d1943e2509 class=n-a></a>Mousavi-Jazi M, Karlberg H, Papa A, <i> et al.</i>: Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine. <i>Vaccine.</i> 2012; <b>30</b>(44): 6225–9. <a target=xrefwindow id=d1943e2520 href="http://www.ncbi.nlm.nih.gov/pubmed/22902680">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2523 href="https://doi.org/10.1016/j.vaccine.2012.08.003">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d1943e2532 class=n-a></a>Papa A, Papadimitriou E, Christova I: The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain. <i>Scand J Infect Dis.</i> 2011; <b>43</b>(3): 225–9. <a target=xrefwindow id=d1943e2540 href="http://www.ncbi.nlm.nih.gov/pubmed/21142621">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2543 href="https://doi.org/10.3109/00365548.2010.540036">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727365409"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2552 class=n-a></a>Hinkula J, Devignot S, Åkerström S, <i> et al.</i>: Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice. <i>J Virol.</i> 2017; <b>91</b>(10): pii: e02076-16. <a target=xrefwindow id=d1943e2563 href="http://www.ncbi.nlm.nih.gov/pubmed/28250124">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2566 href="https://doi.org/10.1128/JVI.02076-16">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2570 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5411611">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727365409">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d1943e2583 class=n-a></a>Ghiasi SM, Salmanian AH, Chinikar S, <i> et al.</i>: Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus. <i>Clin Vaccine Immunol.</i> 2011; <b>18</b>(12): 2031–7. <a target=xrefwindow id=d1943e2594 href="http://www.ncbi.nlm.nih.gov/pubmed/22012978">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2597 href="https://doi.org/10.1128/CVI.05352-11">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2601 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3232705">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d1943e2610 class=n-a></a>Kortekaas J, Vloet RP, McAuley AJ, <i> et al.</i>: Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice. <i>Vector Borne Zoonotic Dis.</i> 2015; <b>15</b>(12): 759–64. <a target=xrefwindow id=d1943e2621 href="http://www.ncbi.nlm.nih.gov/pubmed/26684523">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2624 href="https://doi.org/10.1089/vbz.2015.1855">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d1943e2634 class=n-a></a>Rahpeyma M, Samarbaf-Zadeh A, Makvandi M, <i> et al.</i>: Expression and characterization of codon-optimized Crimean-Congo hemorrhagic fever virus Gn glycoprotein in insect cells. <i>Arch Virol.</i> 2017; <b>162</b>(7): 1951–62. <a target=xrefwindow id=d1943e2645 href="http://www.ncbi.nlm.nih.gov/pubmed/28316015">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2648 href="https://doi.org/10.1007/s00705-017-3315-3">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d1943e2657 class=n-a></a>Zivcec M, Safronetz D, Scott DP, <i> et al.</i>: Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge. <i>PLoS Negl Trop Dis.</i> 2018; <b>12</b>(7): e0006628. <a target=xrefwindow id=d1943e2668 href="http://www.ncbi.nlm.nih.gov/pubmed/30011277">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2671 href="https://doi.org/10.1371/journal.pntd.0006628">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2675 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6062107">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d1943e2684 class=n-a></a>Dowall SD, Buttigieg KR, Findlay-Wilson SJ, <i> et al.</i>: A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease. <i>Hum Vaccin Immunother.</i> 2016; <b>12</b>(2): 519–27. <a target=xrefwindow id=d1943e2695 href="http://www.ncbi.nlm.nih.gov/pubmed/26309231">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2698 href="https://doi.org/10.1080/21645515.2015.1078045">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2702 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5049717">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d1943e2711 class=n-a></a>Soares-Weiser K, Thomas S, Thomson G, <i> et al.</i>: Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. <i>BMC Infect Dis.</i> 2010; <b>10</b>: 207. <a target=xrefwindow id=d1943e2722 href="http://www.ncbi.nlm.nih.gov/pubmed/20626907">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2725 href="https://doi.org/10.1186/1471-2334-10-207">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2729 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2912908">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d1943e2738 class=n-a></a>Ascioglu S, Leblebicioglu H, Vahaboglu H, <i> et al.</i>: Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. <i>J Antimicrob Chemother.</i> 2011; <b>66</b>(6): 1215–22. <a target=xrefwindow id=d1943e2749 href="http://www.ncbi.nlm.nih.gov/pubmed/21482564">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2752 href="https://doi.org/10.1093/jac/dkr136">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d1943e2761 class=n-a></a>Johnson S, Henschke N, Maayan N, <i> et al.</i>: Ribavirin for treating Crimean Congo haemorrhagic fever. <i>Cochrane Database Syst Rev.</i> 2018; <b>6</b>: CD012713. <a target=xrefwindow id=d1943e2772 href="http://www.ncbi.nlm.nih.gov/pubmed/29869797">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2775 href="https://doi.org/10.1002/14651858.CD012713.pub2">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2779 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5994605">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720352525"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2789 class=n-a></a>Koksal I, Yilmaz G, Aksoy F, <i> et al.</i>: The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. <i>J Clin Virol.</i> 2010; <b>47</b>(1): 65–8. <a target=xrefwindow id=d1943e2800 href="http://www.ncbi.nlm.nih.gov/pubmed/19962342">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2803 href="https://doi.org/10.1016/j.jcv.2009.11.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720352525">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733867512"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2816 class=n-a></a>Ergönül Ö, Keske Ş, Çeldir MG, <i> et al.</i>: Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers. <i>Emerg Infect Dis.</i> 2018; <b>24</b>(9): 1642–8. <a target=xrefwindow id=d1943e2827 href="http://www.ncbi.nlm.nih.gov/pubmed/30124196">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2830 href="https://doi.org/10.3201/eid2409.171709">Publisher Full Text </a> | <a target=xrefwindow id=d1943e2834 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6106438">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733867512">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732910794"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e2847 class=n-a></a>Espy N, Pérez-Sautu U, Ramírez de Arellano E, <i> et al.</i>: Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection. <i>J Infect Dis.</i> 2018; <b>217</b>(12): 1952–6. <a target=xrefwindow id=d1943e2858 href="http://www.ncbi.nlm.nih.gov/pubmed/29584885">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2861 href="https://doi.org/10.1093/infdis/jiy163">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732910794">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d1943e2874 class=n-a></a>Negredo A, de la Calle-Prieto F, Palencia-Herrejón E, <i> et al.</i>: Autochthonous Crimean-Congo Hemorrhagic Fever in Spain. <i>N Engl J Med.</i> 2017; <b>377</b>(2): 154–61. <a target=xrefwindow id=d1943e2885 href="http://www.ncbi.nlm.nih.gov/pubmed/28700843">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2888 href="https://doi.org/10.1056/NEJMoa1615162">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d1943e2897 class=n-a></a>Muller MP, Dresser L, Raboud J, <i> et al.</i>: Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. <i>Pharmacotherapy.</i> 2007; <b>27</b>(4): 494–503. <a target=xrefwindow id=d1943e2908 href="http://www.ncbi.nlm.nih.gov/pubmed/17381375">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2911 href="https://doi.org/10.1592/phco.27.4.494">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d1943e2920 class=n-a></a>Devine EB, Kowdley KV, Veenstra DL, <i> et al.</i>: Management strategies for ribavirin-induced hemolytic anemia in the treatment of hepatitis C: clinical and economic implications. <i>Value Health.</i> 2001; <b>4</b>(5): 376–84. <a target=xrefwindow id=d1943e2931 href="http://www.ncbi.nlm.nih.gov/pubmed/11705128">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2934 href="https://doi.org/10.1046/j.1524-4733.2001.45075.x">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d1943e2944 class=n-a></a>Ergonul O: Evidence supports ribavirin use in Crimean-Congo hemorrhagic fever. <i>Int J Infect Dis.</i> 2014; <b>29</b>: 296. <a target=xrefwindow id=d1943e2952 href="http://www.ncbi.nlm.nih.gov/pubmed/25461237">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2955 href="https://doi.org/10.1016/j.ijid.2014.08.016">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d1943e2964 class=n-a></a>Ergonul O: DEBATE (see Elaldi N et al, Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238-244): Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever. <i>J Infect.</i> 2009; <b>59</b>(4): 284-6; author reply 286–9. <a target=xrefwindow id=d1943e2972 href="http://www.ncbi.nlm.nih.gov/pubmed/19699762">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2975 href="https://doi.org/10.1016/j.jinf.2009.08.006">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d1943e2984 class=n-a></a>Ceylan B, Calıca A, Ak O, <i> et al.</i>: Ribavirin is not effective against Crimean-Congo hemorrhagic fever: Observations from the Turkish experience. <i>Int J Infect Dis.</i> 2013; <b>17</b>(10): e799–801. <a target=xrefwindow id=d1943e2995 href="http://www.ncbi.nlm.nih.gov/pubmed/23773242">PubMed Abstract </a> | <a target=xrefwindow id=d1943e2998 href="https://doi.org/10.1016/j.ijid.2013.02.030">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d1943e3007 class=n-a></a>Ascioglu S, Leblebicioglu H, Elaldi N, <i> et al.</i>: Response to Ergonul: Scientific Evidence Versus Personal Beliefs In Crimean-Congo Haemorrhagic Fever Treatment. <i>J Infect.</i> 2009; <b>59</b>(4): 286–9. <a target=xrefwindow id=d1943e3018 href="https://doi.org/10.1016/j.jinf.2009.08.017">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d1943e3027 class=n-a></a>Arda B, Aciduman A, Johnston JC: A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: Ethical considerations. <i>J Med Ethics.</i> 2012; <b>38</b>(2): 117–20. <a target=xrefwindow id=d1943e3035 href="http://www.ncbi.nlm.nih.gov/pubmed/21994465">PubMed Abstract </a> | <a target=xrefwindow id=d1943e3038 href="https://doi.org/10.1136/medethics-2011-100107">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d1943e3047 class=n-a></a>Furuta Y, Takahashi K, Fukuda Y, <i> et al.</i>: In vitro and in vivo activities of anti-influenza virus compound T-705. <i>Antimicrob Agents Chemother.</i> 2002; <b>46</b>(4): 977–81. <a target=xrefwindow id=d1943e3058 href="http://www.ncbi.nlm.nih.gov/pubmed/11897578">PubMed Abstract </a> | <a target=xrefwindow id=d1943e3061 href="https://doi.org/10.1128/AAC.46.4.977-981.2002">Publisher Full Text </a> | <a target=xrefwindow id=d1943e3065 href="http://www.ncbi.nlm.nih.gov/pmc/articles/127093">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718297622"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e3075 class=n-a></a>Oestereich L, Lüdtke A, Wurr S, <i> et al.</i>: Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. <i>Antiviral Res.</i> 2014; <b>105</b>: 17–21. <a target=xrefwindow id=d1943e3086 href="http://www.ncbi.nlm.nih.gov/pubmed/24583123">PubMed Abstract </a> | <a target=xrefwindow id=d1943e3089 href="https://doi.org/10.1016/j.antiviral.2014.02.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718297622">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d1943e3102 class=n-a></a>Rosenke K, Feldmann H, Westover JB, <i> et al.</i>: Use of Favipiravir to Treat Lassa Virus Infection in Macaques. <i>Emerg. Infect. Dis.</i> 2018; <b>24</b>(9): 1696–9. <a target=xrefwindow id=d1943e3113 href="http://www.ncbi.nlm.nih.gov/pubmed/29882740">PubMed Abstract </a> | <a target=xrefwindow id=d1943e3116 href="https://doi.org/10.3201/eid2409.180233">Publisher Full Text </a> | <a target=xrefwindow id=d1943e3120 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6106425">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d1943e3129 class=n-a></a>Safronetz D, Rosenke K, Westover JB, <i> et al.</i>: The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. <i>Sci Rep.</i> 2015; <b>5</b>: 14775. <a target=xrefwindow id=d1943e3140 href="http://www.ncbi.nlm.nih.gov/pubmed/26456301">PubMed Abstract </a> | <a target=xrefwindow id=d1943e3143 href="https://doi.org/10.1038/srep14775">Publisher Full Text </a> | <a target=xrefwindow id=d1943e3147 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4600983">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d1943e3156 class=n-a></a>Raabe VN, Kann G, Ribner BS, <i> et al.</i>: Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever. <i>Clin Infect Dis.</i> 2017; <b>65</b>(5): 855–9. <a target=xrefwindow id=d1943e3167 href="http://www.ncbi.nlm.nih.gov/pubmed/29017278">PubMed Abstract </a> | <a target=xrefwindow id=d1943e3170 href="https://doi.org/10.1093/cid/cix406">Publisher Full Text </a> | <a target=xrefwindow id=d1943e3174 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5682919">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731981049"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e3183 class=n-a></a>Welch SR, Scholte FEM, Flint M, <i> et al.</i>: Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus. <i>Antiviral Res.</i> 2017; <b>147</b>: 91–9. <a target=xrefwindow id=d1943e3194 href="http://www.ncbi.nlm.nih.gov/pubmed/29024765">PubMed Abstract </a> | <a target=xrefwindow id=d1943e3197 href="https://doi.org/10.1016/j.antiviral.2017.10.008">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731981049">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731343229"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d1943e3210 class=n-a></a>Zivcec M, Guerrero LIW, Albariño CG, <i> et al.</i>: Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus. <i>Antiviral Res.</i> 2017; <b>146</b>: 112–20. <a target=xrefwindow id=d1943e3221 href="http://www.ncbi.nlm.nih.gov/pubmed/28842265">PubMed Abstract </a> | <a target=xrefwindow id=d1943e3224 href="https://doi.org/10.1016/j.antiviral.2017.08.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731343229">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Oct 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1715&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1715&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Laboratory of Virology, Division of Intramural Research, NIAID/NIH, Hamilton, Montana, 59840, USA<br/> <p> <div class=margin-bottom> David W. Hawman <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Heinz Feldmann <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1715/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Oct 2018, 7:1715 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.16189.1">https://doi.org/10.12688/f1000research.16189.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Hawman DW and Feldmann H. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17678 data-id=16189 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16189.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1715/v1/pdf?article_uuid=27cff07b-d1b3-4e12-95b6-e1ea53e7709b" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.16189.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Hawman DW and Feldmann H. Recent advances in understanding Crimean–Congo hemorrhagic fever virus [version 1; peer review: 4 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1715 (<a href="https://doi.org/10.12688/f1000research.16189.1" target=_blank>https://doi.org/10.12688/f1000research.16189.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=16189 id=mobile-track-article-signin-16189 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16189?target=/articles/7-1715"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17678 /> <input name=articleId type=hidden value=16189 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Anna Papa</strong>, Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Greece </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Dennis A Bente</strong>, Department of Microbiology & Immunology, Galveston National Laboratory, University of Texas Medical Branch, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Ali Mirazimi</strong>, Department for Laboratory Medicine, Karolinska Institute and Karolinska Hospital University, Sweden; National Veterinary Institute, Sweden </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Eric Bergeron</strong>, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Oct 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1715&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1715&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=13615-39628></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=392-39631></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=40559-39630></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=40561-39629></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1715/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Oct 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Anna Papa</strong>, Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Greece </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Dennis A Bente</strong>, Department of Microbiology & Immunology, Galveston National Laboratory, University of Texas Medical Branch, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ali Mirazimi</strong>, Department for Laboratory Medicine, Karolinska Institute and Karolinska Hospital University, Sweden; National Veterinary Institute, Sweden </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Eric Bergeron</strong>, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1715&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1715/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding Crimean\u2013Congo...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1715/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1715/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1715/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Hawman DW and Feldmann H');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1715/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1715",
            templates : {
                twitter : "Recent advances in understanding Crimean\u2013Congo hemorrhagic.... Hawman DW and Feldmann H, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1715/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding Crimean\u2013Congo hemorrhagic fever virus", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding Crimean\u2013Congo hemorrhagic fever virus", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/16189/17678")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17678");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "39628": 0,
                           "39629": 0,
                           "39630": 0,
                           "39631": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "b1a0dc2d-2ea5-4e49-83df-50b2ad4a54ef";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1715.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1715.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1715.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1715.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1715.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>